1. Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment
   Sinead A. Noonan et al, 2018, Oncotarget CrossRef
2. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer
   Grzegorz Hibner et al, 2018, International Journal of Molecular Sciences CrossRef
3. A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer
   Dennis Poel et al, 2020, Cancer Medicine CrossRef
4. In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines
   Sara Shayan et al, 2023, Iranian Biomedical Journal CrossRef
5. MicroRNAs (miRNAs) in Colorectal Cancer
   Burcin Baran et al, 2019, Oncogenes and Carcinogenesis CrossRef
6. Effects of sunitinib and bevacizumab on VEGF and miRNA levels on corneal neovascularization
   Harun Cakmak et al, 2018, Cutaneous and Ocular Toxicology CrossRef
7. Expression levels and clinical values of miR-92b-3p in breast cancer
   Yu Du et al, 2021, World Journal of Surgical Oncology CrossRef
8. miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L2
   Kreepa G Kooblall et al, 2022, Endocrine-Related Cancer CrossRef
9. Predictive “omic” biomarkers of drug response: Colorectal cancer as a model
   Enrico Mini et al, 2022, Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy CrossRef
10. microRNA‐92b‐3p augments colon cancer development through inhibiting KLF3
    Xuezhong Liu et al, 2023, Journal of Biochemical and Molecular Toxicology CrossRef
11. RETRACTED: Reduced miR-125a-5p level in non-small-cell lung cancer is associated with tumour progression
    Hongxu Liu et al, 2018, Open Biology CrossRef
12. The Clinical Assessment of MicroRNA Diagnostic, Prognostic, and Theranostic Value in Colorectal Cancer
    Hussein Al-Akhrass et al, 2021, Cancers CrossRef
13. Retracted: Epigenetic silenced miR‐125a‐5p could be self‐activated through targeting Suv39H1 in gastric cancer
    Mingzhi Cai et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
14. miR-92b-3p Regulates Cell Cycle and Apoptosis by Targeting CDKN1C, Thereby Affecting the Sensitivity of Colorectal Cancer Cells to Chemotherapeutic Drugs
    Fangqing Zhao et al, 2021, Cancers CrossRef
15. Analyses of miRNA in the ileum of diarrheic piglets caused by Clostridium perfringens type C
    Pengfei Wang et al, 2019, Microbial Pathogenesis CrossRef
16. miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
    Alicia Romero-Lorca et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
17. The Developing Story of Predictive Biomarkers in Colorectal Cancer
    Stergios Boussios et al, 2019, Journal of Personalized Medicine CrossRef
18. miR-181a-2* expression is different amongst carcinomas from the colorectal serrated route
    Alexandra Kondelova et al, 2020, Mutagenesis CrossRef
19. Survival Analysis of Multi-Omics Data Identifies Potential Prognostic Markers of Pancreatic Ductal Adenocarcinoma
    Nitish Kumar Mishra et al, 2019, Frontiers in Genetics CrossRef
20. miRNAs and lncRNAs as Predictive Biomarkers of Response to FOLFOX Therapy in Colorectal Cancer
    Kha Wai Hon et al, 2018, Frontiers in Pharmacology CrossRef
21. miRNA expression changes during the course of neoadjuvant bevacizumab and chemotherapy treatment in breast cancer
    Evita Maria Lindholm et al, 2019, Molecular Oncology CrossRef